Vytrus Biotech S.A. Cash Flow Quality Index
Vytrus Biotech S.A. cash flow quality index. Vytrus Biotech S.A. (VYT) has a Cash Flow Quality Index of 0.50x as of December 2022. Operating cash flow of €225.55K is below net income of €452.79K, suggesting accrual-heavy earnings not yet converted to cash. See Vytrus Biotech S.A. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Vytrus Biotech S.A. (2020–2025)
Cash flow quality index of Vytrus Biotech S.A. from 2020 to 2025. Historical Cash Flow Quality Index for Vytrus Biotech S.A. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore VYT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Vytrus Biotech S.A. Cash Flow Quality Index by Year (2020–2025)
Vytrus Biotech S.A. cash flow quality index by year from 2020 to 2025. Year-by-year earnings quality comparison for Vytrus Biotech S.A.. For the full cash flow conversion analysis, see Vytrus Biotech S.A. operating cash flow efficiency.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▲ +233.2% |
| 2022 | 0.50x | €225.55K | €452.79K | ▼ -65.6% |
| 2021 | 1.45x | €447.92K | €309.17K | ▲ +200.2% |
| 2020 | -1.45x | €-132.47K | €91.60K | — |